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Among all viral diseases affecting small ruminants, bluetongue is the one that affects adversely to an alarming extent. 
The current available diagnosis/serotyping of bluetongue virus (BTV) is time consuming, costly, and requires to screen 
individually for each of the 29 distinct serotypes. The present study was conducted with the objective of developing a 
multiplex reverse transcription PCR (mRT-PCR) assay for serotyping of BTV, especially for serotypes BTV-1, 2, 9, 12, 16, 
21 and 23 predominantly circulating in India. The type specific primers for the selected BTV serotypes were designed 
targeting the serotype specific segment-2 region of BTV based on the reference serotype sequences of Indian isolates 
available in GenBank. The mRT-PCR was conducted in two groups - group A for BTV-1, 9, 12, 21 and group B for BTV-2, 
16 and 23. A panel of 25 BT suspected clinical samples were typed by mRT-PCR. The results were further validated by the 
gold standard serum neutralization test (SNT). A seroprevalence of 60% for BTV- 2, 10% for BTV- 9, 15% for BTV- 1, 
10% for BTV- 16 and 5% for BTV- 23 were observed. Further, we noticed that there was a mixed serotype infection in 10% 
of BTV positive samples. In conclusion, we report the development of a novel mRT-PCR assay for a rapid and cost-
effective nucleic acid based serotyping of BTV having the specificity same as SNT. 
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Introduction 
Bluetongue (BT) is an enzootic, infectious, non-
contagious, arthropod-borne viral disease of 
ruminants and camelid species caused by bluetongue 
virus (BTV), a prototype member of the Orbivirus 
genus in the Reoviridae family1. It is transmitted 
almost exclusively by adult female hematophagous 
midges that belong to the Culicoides genus2. The 
disease is mainly characterized by fever, facial edema, 
hemorrhages, ulceration on the oral mucosa and 
coronitis3. The genome encodes seven structural (VP1 
- VP7) and five non-structural proteins (NS1, NS2,
NS3, NS3/A, NS4)4. There are 29 distinct serotypes
of BTV recognized based on the ability of antibodies
generated during infection of the mammalian host to
neutralize only the homologous virus type5-6. The
genome segments of BTV were grouped into ‘eastern’
or ‘western’ topotypes, where the eastern group
includes isolates from China, South Asia, South-East
Asia and Australia and the western group includes
viruses from America, Africa, Europe and the Middle
East countries7. The serotype specificity is determined
by the variation in the outer capsid proteins more 
specifically the VP2 protein8. Out of the 29 serotypes 
recognized worldwide, 24 serotypes are known to be 
existing in India, either by serology or virus isolation9-12. 
At present nine serotypes of BTV (BTV-1, 2, 3, 9, 10, 
12, 16, 21 and 23) were in circulation mostly from 
southern states of India13. 
Bluetongue is traditionally diagnosed by virus 
isolation, serotyping by neutralization assays, and 
antibody detection in convalescent animals14. Virus 
neutralization assays were used for determination of 
prior infection with different serotypes of BTV15. 
Nucleic acid based detection of different conserved 
segments (all segments except segment 2 and 6) can 
be used for diagnosis of BTV16-20, whereas segment 2 
based PCR will determine the serotype of the virus21. 
Having 29 serotypes of BTV, it is often challenging to 
detect the serotype by neutralization assays as it will 
be time consuming. For effective control of BT 
disease, an early diagnosis and effective prophylactic 
measures are much needed. This hints the need for the 
development of cost effective and early diagnostic 
techniques for serotyping of BTV.  
Multiplex PCR has emerged as a highly efficient 
and sensitive molecular tool for nucleic acid based 









The present study was aimed at standardization of 
multiplex reverse transcription PCR (mRT-PCR) for 
serotyping majorly circulating BTV (BTV- 1, 2, 9, 12, 
16, 21 and 23) in India.  
 
Materials and Methods 
Cell lines, Virus Isolates and Study Samples 
The viral isolates, BTV serotypes 1 and 23 
collected from Vaccine Research Centre, Tamil Nadu 
Veterinary and Animal Sciences University 
(TANUVAS), serotype 2 (isolated at Chittoor district 
in 199523), serotype 9 MBN and K8 (isolated at 
Mahabubnagar and Khammam districts, respectively 
in 2002), serotype 12 (isolated at Adilabad district in 
2011), serotype 16 (collected from VBRI, 
Hyderabad), serotype 21 KMN 07/05 (isolated at 
Karimnagar district in 2005) were used in the study. 
Apart from these, 25 unknown samples suspected for 
BTV were used for the study. These blood samples 
were collected from different field outbreaks occurred 
in Andhra Pradesh during 2012-13. All of these virus 
isolates were propagated in Vero cells. 
 
Genotyping of Bluetongue Virus 
Serotype specific primers (Table 1) were designed 
for BTV- 1, 2, 9, 12, 16, 21 and 23 by using serotype 
specific VP2 segment sequence targeting a region of 
2000 bp to 2500 bp of VP2. These primers were 
designed in a way to achieve optimum annealing with 
a varying amplicon product length for each serotype. 
The serotypes were grouped into two: group A (BTV- 
1, 9, 12 and 21), group B (BTV-2, 16 and 23). 
Primers targeting NS1 (segment 5) of BTV that can 
amplify and detect all the known serotypes of BTV 
served as internal control24. 
 
Multiplex RT-PCR and Serum Neutralization Test 
The viral nucleic acid was extracted using Trizol 
LS reagent (Invitrogen) as per the protocol described 
by the manufacturer. The cDNA was synthesized 
from genomic RNA by using random hexamers and 
M-MLV reverse transcriptase kit (Invitrogen) 
following the manufacturer’s protocol. PCR was 
standardized for serotypes of BTV- 1, 2, 9, 12, 16, 21 
and 23 using each pair of primers. The reaction mix 
consisted of 2.5 μL of 10X PCR buffer, 1.25 U Taq 
DNA polymerase, 10 mM of dNTPs, 10 pmols each 
of forward and reverse primers and 5 μL appropriate 
template cDNA (corresponding to 30 ng of RNA) or 
nuclease free water as a negative control were added 
to the reaction.  
The multiplex RT-PCR for both groups (group A, 
group B) was carried out by targeting specific genetic 
portion of cDNA for each serotype with variable 
product sizes. The reaction was set for a final volume 
of 50 μl for each group individually. The reaction mix 
for group A consisted of 5 μl cDNA each of BTV- 1, 
9, 12 and 21 and for group B consisted 5 μl cDNA 
each of BTV- 2, 16 and 23 as a template, 2.5 U of Taq 
DNA polymerase, 5 μl of 10X DNA polymerase 
buffer, 1 μl of 10 mM dNTP mix, and 5 pmols each of 
multiplex primers. 
The conditions were set as initial denaturation at 
94oC for 3 min followed by 35 cycles each at 94ºC for 
30 sec, 50oC for 30 sec, 72oC for 3 min, and the final 
extension at 72oC for 10 min. The gold standard 
Table 1 — The list of primers used in the study 
SI. No Serotype Primer name Primer sequence 
1 BTV - 1 
(KF563934.1) 
BTV - 1F 5’ CCGCGCAATACACCTAGA 3’ 
2 BTV - 1R 5’ TCTAACCGTTCGTCTCCGTT 3’ 
3 BTV - 2 
(KP339165.1) 
BTV - 2F 5’ AGGCGGATCCATTGGAAGAG 3’ 
4 BTV - 2R 5’ CGATCACTACCTACTGCGCT 3’ 
5 BTV - 9 
(KP339185.1) 
BTV - 9F 5’ CGGTGATGGGATCAACCCTA 3’ 
6 BTV - 9R 5’ CATCGYTTGACGAGCGAATGA 3’ 
7 BTV - 12 
(MK516489.1) 
BTV - 12F 5’ CGCACTGAAGGTATATGCGG 3’ 
8 BTV - 12R 5’ GCGAACCTTGTGTAAGTGArC 3’ 
9 BTV - 16 
(MG710531.1) 
BTV - 16F 5’ GCRGTTAAACAGACGCCATC 3’ 
10 BTV - 16R 5’ GCTCAGYCTGTCCCGACTTT 3’ 
11 BTV - 21 
(KP339235.1) 
BTV - 21F 5’ CGTGGGAAATGTyCTGACGA 3’ 
12 BTV - 21R 5’ GCGTTCTGGCGTCTCTCATA 3’ 
13 BTV - 23 
(KP696691.1) 
BTV - 23F 5’ CAGATGACCCTGCCGTAGC 3’ 
14 BTV - 23R 5’ AACGACTCGTCCAAACCGTG 3’ 




serum neutralization tests  (SNT) was performed to 
validate the results in accordance with the protocol 
described in the World Organisation for Animal 
Health (OIE manual)25. The wells are scored for the 
degree of cytopathic effects (CPE) observed. A CPE 
of 75-100% was considered as negative for serum 
neutralization. 
 
Results and Discussion 
Bluetongue, an enzootic, infectious viral disease 
caused by BTV is mainly characterized by fever, 
facial edema, hemorrhages, and ulceration on the oral 
mucosa and coronitis. The presence of 29 distinct 
serotypes complicates the diagnosis of BTV. Though 
there were several diagnostic aids such as virus 
isolation, serotyping by neutralization assays, 
antibody detection in convalescent animals and 
nucleic acid based detection of different conserved 
segments26, they are often time consuming, costly and 
involves several reactions. The present study has been 
taken up with an objective to develop a diagnostic 
assay based on mRT-PCR. 
Multiplex PCR involves the use of multiple pairs of 
specific primers in the same reaction, which can 
simultaneously amplify multiple targeted regions of 
multiple DNA templates at one time. The VP2 gene 
of BTV was targeted in the study for designing the 
multiplex PCR primers. VP2 is the most variable 
outer capsid layer protein encoded by segment-2 of 
the genome and is the serotype determinant of BTV27-28. 
It is also reported to be the potential target for 
development of serotype specific RT-PCR29. VP2 is a 
viral hemagglutinin that is responsible for cell 
attachment during the initiation of infection30. Based 
on the phylogenetic relationship31 the serotypes 
chosen in the current study can be grouped into two: 
group A (BTV-1, 9, 12 and 21) and group B  
(BTV- 2, 16 and 23) for convenience and specificity 
in multiplex PCR. NS1 is the most abundantly 
expressed cytoplasmic protein during the BTV 
infection. Further, the NS1 is highly conserved 
between the BTV serotypes and OIE recommended 
 it as a target for group specific RT-PCR32. Hence, 
 we used NS1 as an internal control in the  
present study. 
 
Standardization of RT-PCR 
Initially, RT-PCR was setup for each primer pairs 
to optimize the PCR conditions and to avoid the non-
specific amplification and to validate the working 
concentrations of primers. The RT-PCR of BTV 
serotypes 1, 2, 9, 12, 16, 21 and 23 generated 
amplicons of sizes 206 bp, 196 bp, 396 bp, 390 bp, 
500 bp, 546 bp and 590 bp, respectively (Fig. 1). 
There was no non-specific amplification seen, and the 
amplification is seen at respective length for each 
serotype. The previous study performed by Mertens 
and colleagues (2007) for evaluation of different 
primer pairs for serotype specific RT-PCR also 
reported that VP-2 is ideal for nucleic acid based 
 
 
Fig. 1 — Uniplex RT-PCR of known reference BTV serotypes. Lane 1 show amplification of 206 bp for BTV-1, Lane 2 show amplification 
of 196 bp for BTV-2, Lane 3 show amplification of 396 bp for BTV-9, Lane 4 show amplification of 500 bp for BTV-12, Lane 5 show 
amplification of 390 bp for BTV-16, Lane 6 show amplification of 591 bp for BTV-21, Lane 7 show amplification of 274 bp for NS1, Lane 8
show amplification of 548 bp for BTV-23, Lane 9 show no amplification for negative control and Lane M is a 1 kb DNA marker. 




serotyping. However, their study is limited to 
evaluation of different primer pairs for serotyping by 
uniplex RT-PCR. 
 
Standardization of Multiplex RT-PCR 
Multiplex PCR for simultaneous detection of BTV 
and epizootic hemorrhagic disease virus were 
previously reported33. The multiplex PCR can be an 
efficient way for detecting the serotypes of BTV in a 
cost effective and single reaction. Hence, after 
optimizing the conditions in RT-PCR, the multiplex 
RT-PCR was standardized for BTV serotyping in 
two reaction groups. The group-A mRT-PCR 
showed amplification of 196 bp, 396 bp, 500 bp, 
591 bp and 274 bp (Fig. 2) indicating presence of 
BTV- 1, 9, 12, 21 and NS1, respectively. The group  
B mRT-PCR show amplification of 206 bp, 390 bp, 
546 bp and 274 bp (Fig. 2) indicating BTV- 2, 16,  
23 and NS1, respectively. The primers show only  
a specific amplification with the respective  
BTV serotypes. A similar kind of study was 
previously performed by Johnson and colleagues34 for 
identification of BTV- 2, 10, 11, 13 and 17 serotypes 
and was found to be a reliable technique.  
 
Typing of Field BTV Isolates by Multiplex RT-PCR  
(mRT-PCR)   
It is more important to test the clinical samples to 
validate the test. Hence, a panel of 25 BTV suspected 
clinical samples collected from sheep during the BTV 
outbreaks in the year 2012 - 2013 were typed using 
the mRT-PCR as described above. Out of 25 samples 
screened, 20 showed an amplification of 274 bp for 
NS1 (Fig. 3). This indicates that 80% of the cases 
were infected with BTV. Different seroprevalence 
rates were reported previously with a seroprevalence 
ranging from 21.4% to 63%35-41. Climatic factors 
which influence the size of vector populations and 
periods of their seasonal activity play an important 
role in the occurrence of BTV infection in animals42. 
In addition to it, there was an amplification of 196 
bp specific for BTV- 2 in 10 samples, 396 bp specific 
for BTV- 9 in one sample, 206 bp specific for BTV- 1 
in one sample, 390 bp specific for BTV- 16 in one 
sample, and 548 bp specific for BTV- 23 in one 
sample (Fig. 3). It was also observed that there was a 
mixed serotype infection in 3 samples; with an 
amplification of 206 bp and 390 bp specific for BTV- 
1 and 16 in one sample (WGL - 1026), 196 bp and 
396 bp specific for BTV-2 and 9 in the second sample 
(WGL - 1041) and 206 bp and 196 bp specific for 
BTV- 1 and 2 in the third sample (NLG - 1955)  
(Fig. 3). In countries endemic for BT like India, 
mixed serotype infections are common. The previous 
reports43 also suggest the superinfection or circulation 
of multiple serotypes in the sampled flocks. Further, 
we noticed that three samples positive for BTV NS1 
turned out to be negative for tested BTV serotypes 
screened in the present study (Fig. 3). This may be 
due to infection with serotype/s other than the ones 
tested in this study. 
Taken together, we noticed a seroprevalence of 
50% for BTV- 2, 5% for each of BTV- 1, BTV- 16, 
BTV- 23, BTV- 9, BTV- 1 & 2, BTV- 2 & 9, BTV- 1 
& 16, and 15% for other serotypes (Fig. 3 & 4). A 
recent report from India showed seroprevalence of 
65.27% for BTV- 1, 26.38% for BTV- 16, 20.83% for 
BTV- 10, 13.88% for BTV- 9 and 23, and 6.94% for 
BTV- 2 (De et al. 2019). This suggests that the 
serotypes prevalent in India were varying from year to 
year and region to region. In addition, the results of 
mRT-PCR typing of BTV isolates were validated  
by SNT with hyperimmune sera for each of  
the specific BTV serotype. The results of  
SNT correlated with that of the mRT-PCR with  
100% specificity. This indicates that the  
multiplex RT-PCR can be an effective replacement 
for other serotyping tests having great specificity, 




Fig. 2 — Multiplex RT-PCR of known reference BTV serotypes.
Lane 1 show the group A PCR products having amplicon lengths
206 bp, 274 bp, 396 bp, 500 bp, 591 bp for BTV-1, NS1, BTV-9, 
BTV-12, BTV-21 respectively. Lane 2 show no amplification for
negative control with group A primers. Lane 3 show the group B
PCR products having amplicon lengths 196 bp, 274 bp, 390 bp,
548 bp for BTV-2, NS1, BTV-16, BTV-23 respectively. Lane 4 
show no amplification for negative control with group B primers.
Lane M is a 1 kb DNA marker. 




In conclusion, we standardized a VP2 based 
multiplex RT-PCR based diagnostic tool for BTV 
which gives a direct correlation for variation in 
serotypes. This novel multiplex RT-PCR is more 
reliable, cost effective, and rapid test for typing BTV 
serotypes without compromising the specificity of 
serum neutralization test. This assay may also be 
useful in epidemiological surveillance and can be 
made as part of a regular diagnostic regime for testing 
cattle, sheep, and goats. Further, we acknowledge the 
need for screening a large number of clinical samples 
for the test to be validated at a large scale. 
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